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La3+-binding sitemplex I from Escherichia coli in the presence of different metal cations revealed at
least two high afﬁnity metal-binding sites. Membrane-bound or isolated Complex I was activated by K+
(apparent binding constant ∼125 μM) and inhibited by La3+ (IC50= 1 μM). K+ and La3+ do not occupy the
same site. Possible localization of these metal-binding sites and their implication in catalysis are discussed.
© 2009 Elsevier B.V. All rights reserved.1. IntroductionThe structure of the electron donor for Complex I, NADH, having
two negatively charged phosphate groups, and additional positive
charge on the nicotinamide moiety after oxidation, implies electro-
static interactions between NADH/NAD+ and charged amino acid
residues in the nucleotide binding site. We recently showed that
glutamate 95 that resides in the NADH- and FMN-binding cavity of the
NuoF subunit of Escherichia coli Complex I accelerates turnover of the
enzyme by repulsion of the negatively charged phosphates of NADH/
NAD+ [1]. The electrostatic interactions between the ﬂavin and
surrounding negatively charged amino acid residues [2] result in
downshift of the midpoint potential of the primary electron acceptor
of Complex I in comparison to the free ﬂavin (−350 mV [3] versus
−220 mV for free ﬂavin). Binding of the artiﬁcial electron acceptor,
HAR, routinely used for the determination of Complex I activity is
most probably based on an attraction between the opposite charges of
this electron acceptor and the protein in the speciﬁc binding site [4,5].
Taken together, this means that electrostatic interactions play an
important role in the binding and release of substrates and the overall
catalysis by Complex I. Additionally, at physiological conditions of the
bacterial cytoplasm or the mitochondrial matrix, Complex I operates
in the presence of different inorganic cations, such as K+, Na+, Ca2+
and Mg2+, which may modulate the properties of the enzyme.
Therefore, it is of importance to assess how metal cations may affect
Complex I. To the best of our knowledge there have so far been no
systematic studies on this subject. However, it has been reported that; HAR, hexaammineruthenium
arina.verkhovskaya@helsinki.ﬁ
ll rights reserved.potassium phosphate at high concentrations (up to 0.3 M) inhibits the
reduction of HAR by 50%, and stimulates ferricyanide reduction by 40%
[6]. The divalent Ca2+ ion was found to be a weak inhibitor of
mitochondrial Complex I [7]. Mg2+, Ba2+, Mn2+, Co2+, Cu2+were also
shown to have moderate inhibitory effect, but Zn2+ was found to be
more efﬁcient, since it inhibits quinone reductase activity with an IC50
of approximately 10 μM, but did not affect the HAR reduction [8].
Considering the effect of the divalent ions on bacterial Complex I it
was found that in the limited concentration range (5–20 mM) they
can stimulate the native activity of the puriﬁed enzyme in the absence
of lipids [9]. It was also shown that these cations can stabilize “as
prepared” enzyme [9]. Böttcher et al. showed that high ionic strength
regardless of the used cation has an inhibitory effect on the native
activity of bacterial Complex I [10]. It is worth noting, that the effects
of metal ions on mitochondrial Complex I could be more complicated
by the peculiar property of this enzyme to exhibit active and inactive
forms, a transition which is sensitive to Mg2+ and Ca2+ [11,12]. In
contrast, bacterial analogs of Complex I, such as from Paracoccus
denitriﬁcans [13,14], Rhodobacter capsulatus [15] and E. coli (our
unpublished results) do not show this feature, which is why studies of
the effects of metal cations on catalytic properties of Complex I using
the bacterial enzyme could provide data which are more easy to
interpret. In the present study we treated the membrane-bound and
isolated Complex I from E. coli with a number of different cations and
found that metal ions may cause the opposite effects: the enzyme
catalytic activity is stimulated by K+ and inhibited by La3+.
2. Materials and methods
2.1. Bacterial growth and puriﬁcation of Complex I
E. coli MWC215 (SmR ndh::CmR) and GRF-E95Q (with the
replacement of Glu95 in NuoF subunit) [1] strains were grown in LB
Fig. 1. The effect of different metal ions on NADH:HAR oxidoreductase activity of
puriﬁed Complex I. KCl, circles; NaCl, squares; CaCl2, left-pointing triangles; MgCl2,
diamonds; La(CH3COO)3, upward-pointing triangles.
Fig. 2. Dependence of Complex I activity on KCl concentration. (A) Activity of membrane-
bound Complex I. 100% is equivalent to 2.7 μmol×mg−1×min−1. (B) Activity of puriﬁed
Complex I. 100% is equivalent to 120 mol×mg−1×min−1. NADH:HAR oxidoreductase
activity, open circles; NADH:DQ oxidoreductase activity, ﬁlled circles.
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exponential growth phase. Complex I was puriﬁed in two chromato-
graphy steps, using anion exchanger DEAE-Trisacryl M (Bio-Sepra)
columns as described in [16]. The last step was gel ﬁltration on
Superdex 200 prep grade (GE Healthcare). 1 ml of the protein solution
(10 mg/ml) was applied onto 130 ml bed volume of Superdex 200 in
XK16/70 column (GE Healthcare) equilibrated with 50 mM MES/
NaOH, pH6.0, containing 150 mM NaCl, 10% sucrose, 2.5% glycerol and
0.025% DDM. The elution was performed at 0.5 ml/min ﬂow rate.
Pooled fractions containing Complex I were concentrated and frozen
in the liquid nitrogen.
2.2. Measurements of catalytic activity
HAR and DQ reductase activities of puriﬁed or membrane-
bound Complex I were measured as described in [16] in buffer
containing 25 mM HEPES-BTP, pH 7.5 and oxidation of NADH was
followed at 340 nm (ɛ=6.2 mM−1×cm−1). FeCy reductase
activity was measured in the same buffer in the presence of
50 μM NADH, 1 mM FeCy, and reduction of FeCy was followed at
420 nm (ɛ=1 mM−1×cm−1). For the determination of the effects
of different metal cations on HAR, FeCy and DQ reduction by
Complex I, a ﬁxed amount of salts of these metals was added to the
reaction mixture before the start of the reaction with the protein.
Each titration curve presented in the present study is the mean of
at least three independent measurements.
2.3. Analytical procedures
Protein concentrations were determined by the BCA protein assay
reagent kit (Pierce) with bovine serum albumin as a standard.
Concentration of K+ and Na+ ions in protein samples and in reaction
media were veriﬁed using Flame Photometer 243 (Instrumentation
Laboratories).3. Results
3.1. Effect of mono-, di- and trivalent metal ions on Complex I activity
Addition of salts of mono-, di- and trivalent metals into the
incubation medium decreased the NADH:HAR oxidoreductase activity
of membrane-bound Complex I to different extents (Fig. 1). The
monovalent cations K+ and Na+ were the weak inhibitors of Complex
I at concentrations over 10 mM; inhibition by the divalent Mg2+ was
evident when its concentration exceeded 100 μM. The trivalent
lanthanides, La3+, Gd3+, and Dy3+, were found to inhibit Complex I
activity in the micromolar range. In contrast to the other studied
cations, K+ at low concentrations caused a remarkable and signiﬁcant
stimulation of NADH:HAR oxidoreduction that was reversed at higher
K+ concentrations (Fig.1). The stimulation of Complex I activity by KCl
was not dependent on Cl−; titration of the activity by potassium
sulfate or potassium cyanide resulted in the same phenomenon (data
not shown). The measurements were performed in the background of
400 μM of Na+ ions, which derived from the NADH disodium salt.
Addition of NaCl, when using the dipotassium salt of NADH, did not
increase the activity of Complex I.
3.2. Stimulation of Complex I activity by K+
The extent of K+ activationwas signiﬁcantly higher for the puriﬁed
Complex I than for the membrane-bound enzyme (Fig. 2). Washed
membranes contain some K+ (50–100 nmol/mg protein) and
although themembranes are strongly diluted upon themeasurements,
there is a possibility that themembrane-bound Complex I still partially
retains K+. The apparent binding constant for K+ determined by
Fig. 3. The double-reciprocal plots for the NADH:HAR oxidoreduction catalyzed by
puriﬁed Complex I in the presence of 350 μMHAR (A) and 200 μMNADH (B) with (ﬁlled
circles) and without (open circles) 3 mM KCl.
Fig. 4. The effect of lanthanum acetate on NADH:HAR (circles), NADH:FeCy (squares)
and NADH:DQ (triangles) oxidoreductase activities of puriﬁed Complex I. 100% activity
is equivalent to 120 (NADH:HAR oxidoreduction), 190 (NADH:FeCy oxidoreduction)
and 12 (NADH:DQ oxidoreduction) μmol×mg−1×min−1.
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with KCl was found to be 125 μM (Fig. 2B). Ubiquinone reductase
activity of membrane-bound Complex I was also stimulated by K+,
although the increase was only 40% or less (Fig. 2A). The ubiquinone
reductase activity of puriﬁed Complex I was practically insensitive to K
+ (Fig. 2B). However, it should be stressed that this activity is much
lower than the NADH:HAR activity due to the limitation in delivery of
the poorly water-soluble DQ to the active site. Treatment of Complex I
with phospholipids, which improves the quinone accessibility and
results in 2–2.5 fold increase of DQ reduction by puriﬁed Complex I,
cannot be applied for studying K+ effects because of the relatively high
K+ content of the commercially available asolectin. Slight activation of
ferricyanide reduction by potassium by approximately 20% was also
observed (data not shown). The NADH:HAR oxidoreductase activity of
puriﬁed Complex I was increased by RbCl almost to the same extent
and at the same concentration range as by KCl, while CsCl, LiCl and
NH4Clwere found to beweaker activatorswithhalf-maximumeffect at
400–600 μM (data not shown).
3.3. Analysis of the steady-state kinetics in the presence and absence of K+
The kinetic parameters were determined for the NADH:HAR oxido-
reduction from double-reciprocal plots 1/v versus 1/[substrate] using
puriﬁed Complex I (Fig. 3); both, apparent KmNADH and Vmax values were
changed (Fig. 3A) in the presence of K+. The values ofKmequal to 8.7 μM
and Vmax equal to 53 μmol×mg−1×min−1 were obtained in the ab-sence of K+, whereas in the presence of 3 mM KCl (maximum effect),
these values were 10.5 μM and 151 μmol×mg−1×min−1, respectively.
Similar results were obtained upon titration of NADH:HAR oxidoreduc-
tion with HAR (Fig. 3B). Vmax of 52 and 130 μmol×mg−1×min−1 were
calculated in the absence and presence of K+, respectively. The apparent
Km
HARwas found to be of 29 μMwithout K+ versus 70 μM in the presence
of 3mMK+. In order to assess the effect of potassium ions on nucleotide
binding in a more direct way we determined the dissociation constant
for NAD+ in the presence and absence of KCl. We found that KiNAD+ for
the wild type Complex I from E. coli measured in the presence and
absence of 3mMKCl are similarwith a value of about 0.94mM(data not
shown).
3.4. Inhibition of Complex I activity by lanthanides
We found that lanthanides such as La3+, Dy3+ and Gd3+ inhibit
NADH:HAR oxidoreductase activity of Complex I with an IC50 of 1–
2 μM. Ubiquinone reductase activity was much less sensitive to
lanthanides (Fig. 4). The same difference in inhibition of HAR and DQ
reductase activity of Complex I by La3+ ions was observed in
membrane-bound enzyme (data not shown). In contrast, NADH:
ferricyanide oxidoreduction was even stimulated by lanthanum.
However, this effect could be observed at one order of magnitude
higher concentration of lanthanum acetate (Fig. 4). To ﬁnd out
whether La3+ and potassium are bound in the same site yielding the
opposite effect, we titrated Complex I activity with La(III) acetate in
the presence and absence of K+ (data not shown). The obtained KiLa3+
was practically the same (1 and 1.2 μM), indicating independent
binding sites for K+ and La3+ ions.
3.5. The effect of cations on the activity of Complex I with E95Q
substitution in the NuoF subunit
Glu95 is located in the vicinity of FMN in the solvent-exposed
cavity of the NuoF subunit. Recently we have found that this residue
participates in the nucleotide binding and the adjustment of the
midpoint redox potential of the ﬂavin [1]. Being negatively charged
and solvent-exposed, Glu95might also interact with cations and could
thus be involved in the modulation of the activity of the enzyme. In
order to check this possibility we titrated the activity of the puriﬁed
Fig. 5. The effect of K+ and La3+ on NADH:HAR oxidoreductase activity of puriﬁed wild
type (ﬁlled circles) and E95Q mutant (open circles) Complex I. Dependence of the
NADH:HAR oxidoreduction on concentration of lanthanum acetate (A) and KCl (B).
100% activity is equivalent to 120 for wild type and 25 μmol×mg−1×min−1 for E95Q
mutant Complex I.
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the sensitivity of the mutated enzyme to potassium remained
unaltered in comparison to wild type, while the inhibitory effect of
lanthanum decreased in the mutant and became 5 μM versus 1 μM for
wild type Complex I (Fig. 5). The mutation also affected the sensitivity
of NADH:FeCy activity of Complex I to lanthanum. Activation by La3+
in the case of the mutant was only 10% (data not shown) in
comparison to 50% in wild type (Fig. 4).
4. Discussion
K+ is essential for growth of E. coli cells [17] and can always be
found in the bacterial cytoplasm in signiﬁcant concentrations, as well
as in the eukaryotic cytosol and themitochondrial matrix. Therefore, it
is natural that this alkali cation may be involved in modiﬁcation of
enzyme structure and activity. The ﬁrst evidence of such an effect of
potassium ions was published by Boyer et al. in 1942 [18], who
showed strong dependence of pyruvate kinase activity on K+. Since
that time the modulation of catalytic activity by potassium was
repeatedly reported, and K+-binding sites were revealed in resolvedstructures of many enzymes (see for review [19]). K+ ionsmaymodify
the substrate-binding site as was shown for diol dehydratase [20] or
affect via an allosteric mechanism when potassium is not in direct
contact with substrate, but alters the conformational state of the
enzyme. An example of such an effect was reported for pyruvate
dehydrogenase kinase, where potassium perturbs the conformation of
active site in such a way that the afﬁnity of the enzyme for ATP
increases 40 times in the presence of this alkali ion [21].
The low potassium concentration required for Complex I activa-
tion, as well as the high selectivity for K+, indicates that K+
speciﬁcally binds to the enzyme. The K+-binding site should be
located in the hydrophilic domain of Complex I most probably in the
NuoF subunit, since it contains the active site with non-covalently
bound ﬂavin and where NADH is being oxidized. Although bound K+
was not found in the structure of the hydrophilic domain of Complex I
from Thermus thermophilus [2], there is a possibility that the
structural resolution was insufﬁcient to detect the small potassium
cation, or it was washed out during the enzyme puriﬁcation and
crystallization. Alternatively, Complex I from T. thermophilus may
differ from that from E. coli.
Analysis of the kinetic data suggests some properties of the K+-
binding site. The simple hyperbolic shape of the potassium depen-
dence of Complex I activity (Fig. 2) suggests the presence of only one
high afﬁnity K+-binding site. The prominent dependence of Vmax on K
+ upon titration of NADH and HAR, and the lack of potassium effect on
NAD+ binding, indicate that Complex I may be considered as a type II
enzyme with respect to K+ binding, following the classiﬁcation of
monovalent cation-activated enzymes introduced by Page and Di Cera
[19]. In these enzymes K+ does not contact the substrate(s) directly,
but perturbs the conformation of the catalytic site. Considering the
possible location of the K+-binding site in Complex I we suggest that it
should be close to the site of HAR binding, since Km for this electron
acceptor increases 2.4 times (Fig. 3B) in the presence of potassium
ions. It is worth to note that the negatively charged glutamate 95 in
the active site of the NuoF subunit is most likely not involved directly
in binding of either potassium or HAR, since the effect of K+ on NADH:
HAR oxidoreduction catalyzed by the E95Q mutant was comparable
with that in wild type (Fig. 5B). Since the K+ concentration in the E.
coli cytoplasm normally exceeds 100 mM the K+-binding site of
Complex I should be constantly occupied in vivo. Therefore, potassium
depletion upon puriﬁcation of the enzyme results in artiﬁcial effects
such as apparent decrease of the catalytic activity, which must be
taken into account in Complex I studies.
The inhibitory effect of cations such as K+, Na+, Ca2+ and Mg2+ at
relatively high concentration on NADH:HAR reductase activity can
easily be explained by unspeciﬁc screening of the negative charges of
the enzyme responsible for the binding of positively charged HAR. The
efﬁciency of this screening would depend only on the cation charge as
was indeed observed (Fig. 1). However, the surprisingly high afﬁnity
(IC50 of 1 μM) of Complex I to La3+ suggests that this cation should be
speciﬁcally bound. The lower sensitivity of the NADH:HAR and NADH:
ferricyanide oxidoreductase activities of the E95Q mutated Complex I
to La3+ makes possible that the location of the La3+-binding site is in
the vicinity of Glu95 in the NuoF subunit. As Grivennikova et al. [22],
we also found that La3+ is not a strong inhibitor of ubiquinone
reductase activity of the membrane-bound Complex I. The low
efﬁciency of La3+ inhibition in this case when the ubiquinone and
HAR reductase activities are similar, indicates that mainly HAR but not
nucleotide binding is disturbed.
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